A strategy integrated DNA barcoding with metabolomics for screening distinguishable combinatorial chemical quality marker between Pheretima aspergillum and Pheretima vulgaris Chen
Ye Shang , Suyi Liu , Chunxiao Liang , Tenukeguli Tuliebieke , Shujing Chen , Kunze Du , Xiaoxuan Tian , Jin Li , Jun He , Hua Jin , Yanxu Chang
{"title":"A strategy integrated DNA barcoding with metabolomics for screening distinguishable combinatorial chemical quality marker between Pheretima aspergillum and Pheretima vulgaris Chen","authors":"Ye Shang , Suyi Liu , Chunxiao Liang , Tenukeguli Tuliebieke , Shujing Chen , Kunze Du , Xiaoxuan Tian , Jin Li , Jun He , Hua Jin , Yanxu Chang","doi":"10.1016/j.jpba.2025.116716","DOIUrl":null,"url":null,"abstract":"<div><div><em>Pheretima</em> is an animal-derived traditional Chinese medicines (TCMs). The chemical quality markers of <em>Pheretima</em> used to distinguish different species are still ambiguous. Under this premise, a strategy integrated DNA barcoding with metabolomics is promoted for identifying <em>Pheretima</em> and screening distinguishable combinatorial chemical quality marker (DCQ-marker) between <em>Pheretima aspergillum</em> (<em>P. aspergillum</em>) and <em>Pheretima vulgaris</em> Chen (<em>P. vulgaris</em>). As a result, adenosine, adenine, L-phenylalanine and uridine are successfully selected as DCQ-markers between <em>P. aspergillum</em> and <em>P. vulgaris</em>. This study provides convenient strategy for quickly screening DCQ-marker between <em>P. aspergillum</em> and <em>P. vulgaris</em>. It will be meaningful for further promoting quality control on <em>Pheretima</em> and providing a reference for the quality evaluation of other animal-derived TCMs.</div></div>","PeriodicalId":16685,"journal":{"name":"Journal of pharmaceutical and biomedical analysis","volume":"257 ","pages":"Article 116716"},"PeriodicalIF":3.1000,"publicationDate":"2025-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of pharmaceutical and biomedical analysis","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0731708525000573","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CHEMISTRY, ANALYTICAL","Score":null,"Total":0}
引用次数: 0
Abstract
Pheretima is an animal-derived traditional Chinese medicines (TCMs). The chemical quality markers of Pheretima used to distinguish different species are still ambiguous. Under this premise, a strategy integrated DNA barcoding with metabolomics is promoted for identifying Pheretima and screening distinguishable combinatorial chemical quality marker (DCQ-marker) between Pheretima aspergillum (P. aspergillum) and Pheretima vulgaris Chen (P. vulgaris). As a result, adenosine, adenine, L-phenylalanine and uridine are successfully selected as DCQ-markers between P. aspergillum and P. vulgaris. This study provides convenient strategy for quickly screening DCQ-marker between P. aspergillum and P. vulgaris. It will be meaningful for further promoting quality control on Pheretima and providing a reference for the quality evaluation of other animal-derived TCMs.
期刊介绍:
This journal is an international medium directed towards the needs of academic, clinical, government and industrial analysis by publishing original research reports and critical reviews on pharmaceutical and biomedical analysis. It covers the interdisciplinary aspects of analysis in the pharmaceutical, biomedical and clinical sciences, including developments in analytical methodology, instrumentation, computation and interpretation. Submissions on novel applications focusing on drug purity and stability studies, pharmacokinetics, therapeutic monitoring, metabolic profiling; drug-related aspects of analytical biochemistry and forensic toxicology; quality assurance in the pharmaceutical industry are also welcome.
Studies from areas of well established and poorly selective methods, such as UV-VIS spectrophotometry (including derivative and multi-wavelength measurements), basic electroanalytical (potentiometric, polarographic and voltammetric) methods, fluorimetry, flow-injection analysis, etc. are accepted for publication in exceptional cases only, if a unique and substantial advantage over presently known systems is demonstrated. The same applies to the assay of simple drug formulations by any kind of methods and the determination of drugs in biological samples based merely on spiked samples. Drug purity/stability studies should contain information on the structure elucidation of the impurities/degradants.